Merck & Co., Inc.
MRKUpdated . Prices are snapshots and may be delayed.
Merck & Co., Inc. price chart
AI Outlook for Merck & Co., Inc.
Neutral postureMerck's long-term trend is strong, with the price 15.1% above its longer-term moving average, though short-term momentum is negative at -4.3%. The shorter-term moving average is above the longer-term one, supporting a neutral technical posture. The stock is 8.3% below its 52-week high.
- Long-term trend+14.8% vs 200-day average
- Medium-term trend-1.2% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Updated 9h ago. Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Merck & Co., Inc. performance
About Merck & Co., Inc.
Merck & Co., Inc. is a pharmaceuticals company based in the United States, listed on NEW YORK STOCK EXCHANGE, INC. since 1941 (ticker MRK).
The shares trade at a price-to-earnings ratio of 109.6. The dividend yield is 2.87%.
Merck & Co., Inc. market data
What is the price of Merck & Co., Inc. today?
Merck & Co., Inc. (MRK) is at $145.95, −0.69% on the day.
What is the 52-week range of Merck & Co., Inc.?
Over the past year Merck & Co., Inc. has traded between $82.01 and $156.92. It is currently 85% of the way up that range.
What is the P/E ratio of Merck & Co., Inc.?
Merck & Co., Inc. trades at a price-to-earnings ratio of 109.6.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.